Matches in SemOpenAlex for { <https://semopenalex.org/work/W4377138575> ?p ?o ?g. }
Showing items 1 to 72 of
72
with 100 items per page.
- W4377138575 endingPage "110" @default.
- W4377138575 startingPage "106" @default.
- W4377138575 abstract "Introduction. Financing of drug maintenance for patients with rare diseases has been remained one of the main topics in Russian Federation (RF) healthcare. 
 The aim of this article is to present data regarding financing of drug maintenance for patients with life-threatening and chronic progressive rare diseases leading to a reduced life expectancy and disability. 
 Materials and methods. There are considered changes in regional financing structure before (2018) and after (2020) the decision on the redistribution of drug maintenance financing from regional to the federal level for patients with hemolytic uremic syndrome, mucopolysaccharidosis type I, II, VI, juvenile arthritis with systemic onset, unspecified aplastic anemia, hereditary deficiency of factors II (fibrinogen), VII (labile), 
 X (Stuart–Prower). 
 Results. Over 2020, only in 2 regions of the Russian Federation, the cost of drug provision for patients with rare diseases from the “List of life-threatening and chronic progressive rare (orphan) diseases leading to a reduction in life expectancy of citizens or their disability” at the regional level exceeded 500 million rubles in comparison with 6 regions in 2018. In addition, the threshold of 200 million rubles was exceeded in all regions included in the list of 20 regions of the Russian Federation with the highest expenses for drug provision of patients with mentioned rare diseases at the regional level in 2018, while in 2020, only 15 regions spent more than the indicated threshold.
 Limitations. The number of Russian regions with large expenditures from regional funds on drug provision for patients with rare diseases were 20 regions in 2018 and 2020.
 Conclusion. Consistent federalization of drug provision for patients with certain rare diseases in 2019–2020 led to a decrease in funding for the provision of drugs for rare diseases from regional budgets." @default.
- W4377138575 created "2023-05-21" @default.
- W4377138575 creator A5003416601 @default.
- W4377138575 creator A5007367208 @default.
- W4377138575 creator A5009250945 @default.
- W4377138575 creator A5054875291 @default.
- W4377138575 creator A5055019287 @default.
- W4377138575 date "2023-04-28" @default.
- W4377138575 modified "2023-09-26" @default.
- W4377138575 title "Drug maintenance financing of patients with rare diseases: changes on the regional level" @default.
- W4377138575 cites W2160273867 @default.
- W4377138575 cites W2625865516 @default.
- W4377138575 cites W2898020169 @default.
- W4377138575 cites W2955595603 @default.
- W4377138575 cites W7252726 @default.
- W4377138575 doi "https://doi.org/10.47470/0044-197x-2023-67-2-106-110" @default.
- W4377138575 hasPublicationYear "2023" @default.
- W4377138575 type Work @default.
- W4377138575 citedByCount "0" @default.
- W4377138575 crossrefType "journal-article" @default.
- W4377138575 hasAuthorship W4377138575A5003416601 @default.
- W4377138575 hasAuthorship W4377138575A5007367208 @default.
- W4377138575 hasAuthorship W4377138575A5009250945 @default.
- W4377138575 hasAuthorship W4377138575A5054875291 @default.
- W4377138575 hasAuthorship W4377138575A5055019287 @default.
- W4377138575 hasBestOaLocation W43771385751 @default.
- W4377138575 hasConcept C105639569 @default.
- W4377138575 hasConcept C133925201 @default.
- W4377138575 hasConcept C144133560 @default.
- W4377138575 hasConcept C187212893 @default.
- W4377138575 hasConcept C2780035454 @default.
- W4377138575 hasConcept C2908647359 @default.
- W4377138575 hasConcept C3019953208 @default.
- W4377138575 hasConcept C60644358 @default.
- W4377138575 hasConcept C71924100 @default.
- W4377138575 hasConcept C75480439 @default.
- W4377138575 hasConcept C86803240 @default.
- W4377138575 hasConcept C98274493 @default.
- W4377138575 hasConcept C99454951 @default.
- W4377138575 hasConceptScore W4377138575C105639569 @default.
- W4377138575 hasConceptScore W4377138575C133925201 @default.
- W4377138575 hasConceptScore W4377138575C144133560 @default.
- W4377138575 hasConceptScore W4377138575C187212893 @default.
- W4377138575 hasConceptScore W4377138575C2780035454 @default.
- W4377138575 hasConceptScore W4377138575C2908647359 @default.
- W4377138575 hasConceptScore W4377138575C3019953208 @default.
- W4377138575 hasConceptScore W4377138575C60644358 @default.
- W4377138575 hasConceptScore W4377138575C71924100 @default.
- W4377138575 hasConceptScore W4377138575C75480439 @default.
- W4377138575 hasConceptScore W4377138575C86803240 @default.
- W4377138575 hasConceptScore W4377138575C98274493 @default.
- W4377138575 hasConceptScore W4377138575C99454951 @default.
- W4377138575 hasIssue "2" @default.
- W4377138575 hasLocation W43771385751 @default.
- W4377138575 hasOpenAccess W4377138575 @default.
- W4377138575 hasPrimaryLocation W43771385751 @default.
- W4377138575 hasRelatedWork W2317042731 @default.
- W4377138575 hasRelatedWork W2409957712 @default.
- W4377138575 hasRelatedWork W2426261983 @default.
- W4377138575 hasRelatedWork W2991844716 @default.
- W4377138575 hasRelatedWork W3015790694 @default.
- W4377138575 hasRelatedWork W4247610422 @default.
- W4377138575 hasRelatedWork W4295066334 @default.
- W4377138575 hasRelatedWork W4300283912 @default.
- W4377138575 hasRelatedWork W4307870143 @default.
- W4377138575 hasRelatedWork W4377942654 @default.
- W4377138575 hasVolume "67" @default.
- W4377138575 isParatext "false" @default.
- W4377138575 isRetracted "false" @default.
- W4377138575 workType "article" @default.